A mouse model of basal-like breast carcinoma with metaplastic elements
- PMID: 17212342
- DOI: 10.1002/path.2124
A mouse model of basal-like breast carcinoma with metaplastic elements
Abstract
Breast cancers arising in carriers of germline BRCA1 mutations frequently have a basal-like phenotype. Basal-like cancers are characterized by high histological grade, central necrotic areas, foci with metaplastic differentiation, lack of hormone receptor and HER2 (ErbB2) expression, and consistent positivity for basal markers, including CK5/6, CK14, and EGFR. We have used germline manipulation to generate a conditional mouse model of Brca1 deficiency. Transgenic expression of Cre recombinase in the mammary gland of these mice results in deletion of exons encoding the C-terminus of Brca1 and leads to tumour formation when combined with heterozygosity for a p53 mutation. Histologically, these mammary gland tumours were characterized by high histological grade, central necrotic areas, and presence of homologous metaplastic elements. These metaplastic elements consisted of neoplastic spindle cells or squamous cell differentiation in the form of keratin pearls or individual cell keratinization. Immunohistochemical analysis revealed expression of basal-like markers in all cases. The tumour phenotype generated in our mouse model was compared with published data on human basal-like breast carcinomas and also with metaplastic breast cancers with a basal-like phenotype; the comparison showed that we have generated a mouse model of basal-like breast cancer, which should prove useful in testing new and targeted treatments for this type of breast cancer.
Copyright (c) 2007 Pathological Society of Great Britain and Ireland.
Similar articles
-
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.Breast Cancer Res. 2011 Mar 11;13(2):R30. doi: 10.1186/bcr2850. Breast Cancer Res. 2011. PMID: 21396117 Free PMC article.
-
Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model.Dis Model Mech. 2021 May 1;14(5):dmm048736. doi: 10.1242/dmm.048736. Epub 2021 May 18. Dis Model Mech. 2021. PMID: 34003256 Free PMC article.
-
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12111-6. doi: 10.1073/pnas.0702969104. Epub 2007 Jul 11. Proc Natl Acad Sci U S A. 2007. PMID: 17626182 Free PMC article.
-
The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling.J Mammary Gland Biol Neoplasia. 2011 Apr;16(1):51-5. doi: 10.1007/s10911-011-9202-8. Epub 2011 Feb 19. J Mammary Gland Biol Neoplasia. 2011. PMID: 21336547 Review.
-
A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):99-116. doi: 10.1007/s10911-009-9120-1. Epub 2009 Apr 30. J Mammary Gland Biol Neoplasia. 2009. PMID: 19408105 Review.
Cited by
-
Histological and molecular types of breast cancer: is there a unifying taxonomy?Nat Rev Clin Oncol. 2009 Dec;6(12):718-30. doi: 10.1038/nrclinonc.2009.166. Nat Rev Clin Oncol. 2009. PMID: 19942925 Review.
-
Oncogenes and tumor suppressor genes.Cold Spring Harb Perspect Biol. 2010 Oct;2(10):a003236. doi: 10.1101/cshperspect.a003236. Epub 2010 Aug 18. Cold Spring Harb Perspect Biol. 2010. PMID: 20719876 Free PMC article. Review.
-
HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1.Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2622-7. doi: 10.1073/pnas.0914492107. Epub 2010 Jan 22. Proc Natl Acad Sci U S A. 2010. PMID: 20133759 Free PMC article.
-
Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type.Cancer Cell. 2011 May 17;19(5):640-51. doi: 10.1016/j.ccr.2011.03.011. Cancer Cell. 2011. PMID: 21575864 Free PMC article.
-
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs.Cancer Sci. 2016 Feb;107(2):189-202. doi: 10.1111/cas.12857. Cancer Sci. 2016. PMID: 26919617 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
